{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:46:49Z","timestamp":1784882809720,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81560387"],"award-info":[{"award-number":["81560387"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902983"],"award-info":[{"award-number":["81902983"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2018JJB140382"],"award-info":[{"award-number":["2018JJB140382"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u201cMedical Excellence Award\u201d funded by the creative research development grant from the first affiliated hospital of Guangxi Medical University","award":["180327"],"award-info":[{"award-number":["180327"]}]},{"name":"Guangxi medical and health technology development and application project)","award":["S2019097"],"award-info":[{"award-number":["S2019097"]}]},{"name":"Guangxi medical and health technology development and application project","award":["S2018100"],"award-info":[{"award-number":["S2018100"]}]},{"name":"Emergency and Medical Rescue Talent Small Highland in Guangxi Zhuang Autonomous Region \u2022 Open Topics of Key Laboratory for Emergency Medicine in Guangxi Universities","award":["GXJZ201501"],"award-info":[{"award-number":["GXJZ201501"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The feasibility of association liver partition and portal vein ligation for staged hepatectomy (ALPPS) for solitary huge hepatocellular carcinoma (HCC, maximal diameter \u2265 10 cm) remains uncertain. This study aims to evaluate the safety and the efficacy of ALPPS for patients with solitary huge HCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty patients with solitary huge HCC who received ALPPS during January 2017 and December 2019 were retrospectively analyzed. The oncological characteristics of contemporaneous patients who underwent one-stage resection and transcatheter arterial chemoembolization (TACE) were compared using propensity score matching (PSM).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All patients underwent complete two-staged ALPPS. The median future liver remnant from the ALPPS-I stage to the ALPPS-II stage increased by 64.5% (range = 22.3\u2013221.9%) with a median interval of 18 days (range = 10\u201354 days). The 90-day mortality rate after the ALPPS-II stage was 5%. The 1- and 3-year overall survival (OS) rates were 70.0% and 57.4%, respectively, whereas the 1- and 3-year progression-free survival (PFS) rates were 60.0% and 43.0%, respectively. In the one-to-one PSM analysis, the long-term survival of patients who received ALPPS was significantly better than those who received TACE (OS, <jats:italic>P<\/jats:italic> = 0.007; PFS, <jats:italic>P<\/jats:italic> = 0.011) but comparable with those who underwent one-stage resection (OS, <jats:italic>P<\/jats:italic> = 0.463; PFS, <jats:italic>P<\/jats:italic> = 0.786).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The surgical outcomes of ALPPS were superior to those of TACE and similar to those of one-stage resection. ALPPS is a safe and effective treatment strategy for patients with unresectable solitary huge HCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-021-02199-1","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T17:03:01Z","timestamp":1617123781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study"],"prefix":"10.1186","volume":"19","author":[{"given":"Zhenfeng","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongrui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4268-540X","authenticated-orcid":false,"given":"Zhang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"issue":"6","key":"2199_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-A Cancer Journal For Clinicians. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"Ca-A Cancer Journal For Clinicians."},{"issue":"1","key":"2199_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358\u201380. https:\/\/doi.org\/10.1002\/hep.29086.","journal-title":"Hepatology."},{"issue":"2","key":"2199_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/SLA.0000000000000236","volume":"260","author":"JH Zhong","year":"2014","unstructured":"Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L, Ye XP, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg. 2014;260(2):329\u201340. https:\/\/doi.org\/10.1097\/SLA.0000000000000236.","journal-title":"Ann Surg."},{"issue":"7","key":"2199_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000495","volume":"94","author":"H Xiao","year":"2015","unstructured":"Xiao H, Zhang B, Mei B, Zuo C, Wei G, Wang R, et al. Hepatic resection for hepatocellular carcinoma in patients with portal hypertension: a long-term benefit compared with transarterial chemoembolization and thermal ablation. Medicine. 2015;94(7):e495. https:\/\/doi.org\/10.1097\/MD.0000000000000495.","journal-title":"Medicine."},{"issue":"4","key":"2199_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","volume":"11","author":"M Omata","year":"2017","unstructured":"Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317\u201370. https:\/\/doi.org\/10.1007\/s12072-017-9799-9.","journal-title":"Hepatol Int."},{"issue":"5","key":"2199_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jamcollsurg.2003.07.013","volume":"197","author":"K Mok","year":"2003","unstructured":"Mok K, Wang B, Lo G, et al. Multimodality management of hepatocellular carcinoma larger than 10 cm. J Am Coll Surgeons. 2003;197(5):730\u20138. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2003.07.013.","journal-title":"J Am Coll Surgeons."},{"issue":"5","key":"2199_CR7","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/jgh.12504","volume":"29","author":"YW Min","year":"2014","unstructured":"Min YW, Lee JH, Gwak G-Y, Paik YH, Lee JH, Rhee PL, et al. Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching. J Gastroen Hepatol. 2014;29(5):1043\u20138. https:\/\/doi.org\/10.1111\/jgh.12504.","journal-title":"J Gastroen Hepatol."},{"issue":"6","key":"2199_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.hbpd.2019.09.001","volume":"18","author":"Q Fang","year":"2019","unstructured":"Fang Q, Xie QS, Chen JM, Shan SL, Xie K, Geng XP, et al. Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: a single-center experience in China. Hepatobiliary Pancreat Dis Int. 2019;18(6):532\u20137. https:\/\/doi.org\/10.1016\/j.hbpd.2019.09.001.","journal-title":"Hepatobiliary Pancreat Dis Int."},{"issue":"3","key":"2199_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","volume":"255","author":"AA Schnitzbauer","year":"2012","unstructured":"Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255(3):405\u201314. https:\/\/doi.org\/10.1097\/SLA.0b013e31824856f5.","journal-title":"Ann Surg."},{"issue":"8","key":"2199_CR10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.ejso.2014.04.002","volume":"40","author":"G Vennarecci","year":"2014","unstructured":"Vennarecci G, Laurenzi A, Levi Sandri GB, Busi Rizzi E, Cristofaro M, Montalbano M, et al. The ALPPS procedure for hepatocellular carcinoma. Eur J Surg Oncol. 2014;40(8):982\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2014.04.002.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"2199_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/SLA.0000000000002942","volume":"271","author":"Z Wang","year":"2018","unstructured":"Wang Z, Peng Y, Hu J, et al. Associating liver partition and portal vein ligation for staged hepatectomy for unresectable hepatitis B virus-related hepatocellular carcinoma: a single center study of 45 patients. Ann Surg. 2018;271(3):534\u201341.","journal-title":"Ann Surg."},{"issue":"1","key":"2199_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/SLA.0000000000002797","volume":"269","author":"H Lang","year":"2018","unstructured":"Lang H, de Santibanes E, Schlitt HJ, et al. 10th anniversary of ALPPS-lessons learned and quo vadis. Ann Surg. 2018;269(1):114\u20139.","journal-title":"Ann Surg."},{"issue":"5","key":"2199_CR13","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/SLA.0000000000002446","volume":"266","author":"M Linecker","year":"2017","unstructured":"Linecker M, Bjornsson B, Stavrou GA, et al. Risk adjustment in ALPPS is associated with a dramatic decrease in early mortality and morbidity. Ann Surg. 2017;266(5):779\u201386. https:\/\/doi.org\/10.1097\/SLA.0000000000002446.","journal-title":"Ann Surg."},{"issue":"3","key":"2199_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/jgh.12865","volume":"30","author":"W Kemp","year":"2015","unstructured":"Kemp W, Levy M, Weltman M, Lubel J, Australian Liver Association (ALA). Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis. J Gastroen Hepatol. 2015;30(3):453\u201362. https:\/\/doi.org\/10.1111\/jgh.12865.","journal-title":"J Gastroen Hepatol."},{"issue":"12","key":"2199_CR15","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.14309\/ajg.0000000000000461","volume":"114","author":"N Cazzagon","year":"2019","unstructured":"Cazzagon N, Lemoinne S, El Mouhadi S, et al. The complementary value of magnetic resonance imaging and vibration-controlled transient elastography for risk stratification in primary sclerosing cholangitis. Am J Gastroenterol. 2019;114(12):1878\u201385. https:\/\/doi.org\/10.14309\/ajg.0000000000000461.","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"2199_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/apt.13488","volume":"43","author":"Y Li","year":"2016","unstructured":"Li Y, Huang YS, Wang ZZ, Yang ZR, Sun F, Zhan SY, et al. Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2016;43(4):458\u201369. https:\/\/doi.org\/10.1111\/apt.13488.","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"2199_CR17","first-page":"302","volume":"40","author":"F Li","year":"2009","unstructured":"Li F, Yan L, Li B, Zeng Y, Wen TF, Xu MQ, et al. Estimation formula of standard liver volume for Chinese adults. Sichuan da xue xue bao: Yi xue ban. 2009;40(2):302\u20136.","journal-title":"Sichuan da xue xue bao: Yi xue ban."},{"issue":"5","key":"2199_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/SLA.0000000000001633","volume":"263","author":"KJ Oldhafer","year":"2016","unstructured":"Oldhafer KJ, Stavrou GA, van Gulik TM, Core Group. ALPPS--where do we stand, where do we go?: eight recommendations from the first international expert meeting. Ann Surg. 2016;263(5):839\u201341. https:\/\/doi.org\/10.1097\/SLA.0000000000001633.","journal-title":"Ann Surg."},{"key":"2199_CR19","unstructured":"Propensity score matching in SPSS. January 30, 2012. https:\/\/arxiv.org\/abs\/1201.6385 Accessed 1 Jan 2017."},{"issue":"5","key":"2199_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/SLA.0000000000002511","volume":"267","author":"P Sandstrom","year":"2018","unstructured":"Sandstrom P, Rosok BI, Sparrelid E, et al. ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a Scandinavian multicenter randomized controlled trial (LIGRO Trial). Ann Surg. 2018;267(5):833\u201340. https:\/\/doi.org\/10.1097\/SLA.0000000000002511.","journal-title":"Ann Surg."},{"issue":"4","key":"2199_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/SLA.0000000000001046","volume":"261","author":"FA Alvarez","year":"2015","unstructured":"Alvarez FA, Ardiles V, de Santibanes M, et al. Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. Ann Surg. 2015;261(4):723\u201332. https:\/\/doi.org\/10.1097\/SLA.0000000000001046.","journal-title":"Ann Surg."},{"issue":"6","key":"2199_CR22","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1245\/s10434-014-4291-4","volume":"22","author":"F Ratti","year":"2015","unstructured":"Ratti F, Schadde E, Masetti M, Massani M, Zanello M, Serenari M, et al. Strategies to increase the resectability of patients with colorectal liver metastases: a multi-center case-match analysis of ALPPS and conventional two-stage hepatectomy. Ann Surg Oncol. 2015;22(6):1933\u201342. https:\/\/doi.org\/10.1245\/s10434-014-4291-4.","journal-title":"Ann Surg Oncol."},{"issue":"32","key":"2199_CR23","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.3748\/wjg.v21.i32.9630","volume":"21","author":"SL Zhu","year":"2015","unstructured":"Zhu SL, Zhong JH, Ke Y, Ma L, You XM, Li LQ. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma. World J Gastroentero. 2015;21(32):9630\u20137. https:\/\/doi.org\/10.3748\/wjg.v21.i32.9630.","journal-title":"World J Gastroentero."},{"issue":"5","key":"2199_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.21037\/atm.2019.12.157","volume":"8","author":"CY Wei","year":"2020","unstructured":"Wei CY, Chen PC, Chau GY, Lee RC, Chen PH, Huo TI, et al. Comparison of prognosis between surgical resection and transarterial chemoembolization for patients with solitary huge hepatocellular carcinoma. Ann Transl Med. 2020;8(5):238. https:\/\/doi.org\/10.21037\/atm.2019.12.157.","journal-title":"Ann Transl Med."},{"key":"2199_CR25","doi-asserted-by":"publisher","unstructured":"Chan A, Zhang WY, Chok K, et al. ALPPS versus portal vein embolization for hepatitis-related hepatocellular carcinoma: a changing paradigm in modulation of future liver remnant before major hepatectomy. Ann Surg. 2019. Volume published online ahead of print. https:\/\/doi.org\/10.1097\/SLA.0000000000003433.","DOI":"10.1097\/SLA.0000000000003433"},{"issue":"1","key":"2199_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejso.2016.05.026","volume":"43","author":"GK Glantzounis","year":"2017","unstructured":"Glantzounis GK, Tokidis E, Basourakos SP, Ntzani EE, Lianos GD, Pentheroudakis G. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg Oncol. 2017;43(1):32\u201341. https:\/\/doi.org\/10.1016\/j.ejso.2016.05.026.","journal-title":"Eur J Surg Oncol."},{"issue":"9","key":"2199_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4254\/wjh.v8.i9.439","volume":"8","author":"T Aoki","year":"2016","unstructured":"Aoki T, Kubota K. Preoperative portal vein embolization for hepatocellular carcinoma: consensus and controversy. World J Hepatol. 2016;8(9):439\u201345. https:\/\/doi.org\/10.4254\/wjh.v8.i9.439.","journal-title":"World J Hepatol."},{"issue":"2","key":"2199_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11605-007-0410-x","volume":"12","author":"B Aussilhou","year":"2008","unstructured":"Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg. 2008;12(2):297\u2013303. https:\/\/doi.org\/10.1007\/s11605-007-0410-x.","journal-title":"J Gastrointest Surg."},{"issue":"2","key":"2199_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jamcollsurg.2012.10.018","volume":"216","author":"J Shindoh","year":"2013","unstructured":"Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg. 2013;216(2):201\u20139. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2012.10.018.","journal-title":"J Am Coll Surg."},{"key":"2199_CR30","doi-asserted-by":"publisher","unstructured":"Hasselgren K, Rosok BI, Larsen PN, et al. ALPPS improves survival compared with TSH in patients affected of CRLM: survival analysis from the randomized controlled trial LIGRO. Ann Surg. 2021;273(3):442\u20138. https:\/\/doi.org\/10.1097\/SLA.0000000000003701.","DOI":"10.1097\/SLA.0000000000003701"},{"issue":"13","key":"2199_CR31","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/bjs.10290","volume":"103","author":"D Eshmuminov","year":"2016","unstructured":"Eshmuminov D, Raptis DA, Linecker M, Wirsching A, Lesurtel M, Clavien PA. Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy. Br J Surg. 2016;103(13):1768\u201382. https:\/\/doi.org\/10.1002\/bjs.10290.","journal-title":"Br J Surg."},{"key":"2199_CR32","doi-asserted-by":"publisher","unstructured":"Hernandez-Alejandro R, Ruffolo LI, Alikhanov R, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for colorectal liver metastasis. Int J Surg. 2020;82(Supplement):103\u20138. https:\/\/doi.org\/10.1016\/j.ijsu.2020.04.009.","DOI":"10.1016\/j.ijsu.2020.04.009"},{"issue":"6","key":"2199_CR33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1503\/cjs.005817","volume":"60","author":"I Al Hasan","year":"2017","unstructured":"Al Hasan I, Tun-Abraham ME, Wanis KN, et al. Optimizing associated liver partition and portal vein ligation for staged hepatectomy outcomes: surgical experience or appropriate patient selection? Can J Surg. 2017;60(6):408\u201315. https:\/\/doi.org\/10.1503\/cjs.005817.","journal-title":"Can J Surg."},{"issue":"43","key":"2199_CR34","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.3748\/wjg.v25.i43.6373","volume":"25","author":"KP Au","year":"2019","unstructured":"Au KP, Chan ACY. Current status of associating liver partition with portal vein ligation for staged hepatectomy: comparison with two-stage hepatectomy and strategies for better outcomes. World J Gastroenterol. 2019;25(43):6373\u201385. https:\/\/doi.org\/10.3748\/wjg.v25.i43.6373.","journal-title":"World J Gastroenterol."},{"issue":"6","key":"2199_CR35","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, de Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696\u20139. https:\/\/doi.org\/10.1016\/0168-8278(95)80226-6.","journal-title":"J Hepatol."},{"issue":"5","key":"2199_CR36","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","volume":"149","author":"NN Rahbari","year":"2011","unstructured":"Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713\u201324. https:\/\/doi.org\/10.1016\/j.surg.2010.10.001.","journal-title":"Surgery."},{"issue":"2","key":"2199_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg."},{"issue":"2","key":"2199_CR38","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1097\/SLA.0000000000001967","volume":"265","author":"K Tanaka","year":"2017","unstructured":"Tanaka K, Kikuchi Y, Kawaguchi D, Murakami T, Hiroshima Y, Matsuo K. Modified ALPPS procedures avoiding division of portal pedicles. Ann Surg. 2017;265(2):e14\u201320. https:\/\/doi.org\/10.1097\/SLA.0000000000001967.","journal-title":"Ann Surg."},{"issue":"9","key":"2199_CR39","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/bjs.9547","volume":"101","author":"R Robles","year":"2014","unstructured":"Robles R, Parrilla P, Lopez-Conesa A, et al. Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure. Br J Surg. 2014;101(9):1129\u201334. https:\/\/doi.org\/10.1002\/bjs.9547.","journal-title":"Br J Surg."},{"issue":"6","key":"2199_CR40","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/SLA.0000000000000234","volume":"259","author":"RT Groeschl","year":"2014","unstructured":"Groeschl RT, Pilgrim CH, Hanna EM, et al. Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg. 2014;259(6):1195\u2013200. https:\/\/doi.org\/10.1097\/SLA.0000000000000234.","journal-title":"Ann Surg."},{"issue":"2","key":"2199_CR41","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/SLA.0000000000000607","volume":"261","author":"TM Gall","year":"2015","unstructured":"Gall TM, Sodergren MH, Frampton AE, et al. Radio-frequency-assisted liver partition with portal vein ligation (RALPP) for liver regeneration. Ann Surg. 2015;261(2):e45\u20136. https:\/\/doi.org\/10.1097\/SLA.0000000000000607.","journal-title":"Ann Surg."},{"issue":"4","key":"2199_CR42","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1097\/SLA.0000000000001087","volume":"261","author":"H Petrowsky","year":"2015","unstructured":"Petrowsky H, Gyori G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? A single-center experience. Ann Surg. 2015;261(4):e90\u20132. https:\/\/doi.org\/10.1097\/SLA.0000000000001087.","journal-title":"Ann Surg."},{"issue":"9","key":"2199_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3760\/cma.j.issn.0529-5815.2016.09.005","volume":"54","author":"L Chen","year":"2016","unstructured":"Chen L, Luo H, Dong S, Chen XP. Safety assessment of hepatectomy for huge hepatocellular carcinoma by three dimensional reconstruction technique. Zhonghua wai ke za zhi. 2016;54(9):669\u201374. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-5815.2016.09.005.","journal-title":"Zhonghua wai ke za zhi."},{"issue":"2","key":"2199_CR44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/RCT.0000000000000995","volume":"44","author":"AAK Abdel Razek","year":"2020","unstructured":"Abdel Razek AAK, El-Serougy LG, Saleh GA, et al. Liver Imaging Reporting and Data System Version 2018: what radiologists need to know. J Comput Assist Tomogr. 2020;44(2):168\u201377. https:\/\/doi.org\/10.1097\/RCT.0000000000000995.","journal-title":"J Comput Assist Tomogr."},{"issue":"9","key":"2199_CR45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.diii.2020.03.008","volume":"101","author":"AAK Abdel Razek","year":"2020","unstructured":"Abdel Razek AAK, El-Serougy LG, Saleh GA, et al. Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy. Diagn Interv Imaging. 2020;101(9):547\u201353. https:\/\/doi.org\/10.1016\/j.diii.2020.03.008.","journal-title":"Diagn Interv Imaging."},{"issue":"6","key":"2199_CR46","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1245\/s10434-014-4099-2","volume":"22","author":"A Vitale","year":"2014","unstructured":"Vitale A. Huo T-l, Cucchetti A, et al. Survival benefit of liver transplantation versus resection for hepatocellular carcinoma: impact of MELD score. Ann Surg Oncol. 2014;22(6):1901\u20137. https:\/\/doi.org\/10.1245\/s10434-014-4099-2.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"2199_CR47","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1245\/s10434-014-4350-x","volume":"22","author":"N Kishida","year":"2015","unstructured":"Kishida N, Hibi T, Itano O, Okabayashi K, Shinoda M, Kitago M, et al. Validation of hepatectomy for elderly patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22(9):3094\u2013101. https:\/\/doi.org\/10.1245\/s10434-014-4350-x.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"2199_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13304-017-0486-0","volume":"70","author":"R Pravisani","year":"2018","unstructured":"Pravisani R, Baccarani U, Isola M, Adani G, Lorenzin D, Terrosu G, et al. Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection. Updates Surg. 2018;70(1):57\u201366. https:\/\/doi.org\/10.1007\/s13304-017-0486-0.","journal-title":"Updates Surg."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-021-02199-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T17:03:59Z","timestamp":1617123839000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-021-02199-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2199"],"URL":"https:\/\/doi.org\/10.1186\/s12957-021-02199-1","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]},"assertion":[{"value":"13 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of First Affiliated Hospital of Guangxi Medical University (approval number: 2020KY-E-110).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}